Jim Simons’s Redhill Biopharma RDHL Stock Holding History

Jim Simons’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-349	Closed	-$49K	–	4309
2022 Q4	$49K	Buy	+349	New	+$151K	﹤0.01%	3799
2021 Q3	–	Sell	-20	Closed	-$137K	–	3777
2021 Q2	$137K	Buy	+20	New	+$138K	﹤0.01%	3320
2018 Q4	–	Sell	-139	Closed	-$1.23M	–	3566
2018 Q3	$1.23M	Buy	+139	New	+$1.13M	﹤0.01%	2522
2017 Q3	–	Sell	-25	Closed	-$216K	–	3333
2017 Q2	$216K	Sell	25 -37	-60%	-$356K	﹤0.01%	2981
2017 Q1	$595K	Buy	62 +37	+148%	+$370K	﹤0.01%	2718
2016 Q4	$266K	Buy	+25	New	+$300K	﹤0.01%	2940
2015 Q3	–	Sell	-27	Closed	-$472K	–	3326
2015 Q2	$472K	Buy	+27	New	+$429K	﹤0.01%	2740

Other funds holding RDHL

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Jim Simons's RDHL Position: Q1 2023 in Review

Jim Simons sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 349 shares — an estimated $49K sold.

Jim Simons first reported a position in RDHL in Q2 2015 and held it in 7 quarters. The position peaked at $1.23M in Q3 2018. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

Jim Simons reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
Jim Simons sold 349 Redhill Biopharma shares in Q1 2023, an estimated $49K.
Jim Simons first reported a position in Redhill Biopharma in Q2 2015 and held it in 7 quarters.
Jim Simons's Redhill Biopharma position peaked at $1.23M in Q3 2018.
16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.